{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      " COVID-19",
      "SARS-CoV-2 seroprevalence",
      "antibody testing",
      "spectrum bias",
      "test performance"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32856712",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "jiaa523",
      "10.1093/infdis/jiaa523"
    ],
    "Journal": {
      "ISSN": "1537-6613",
      "JournalIssue": {
        "Volume": "222",
        "Issue": "11",
        "PubDate": {
          "Year": "2020",
          "Month": "Nov",
          "Day": "09"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?",
    "Pagination": {
      "StartPage": "1772",
      "EndPage": "1775",
      "MedlinePgn": "1772-1775"
    },
    "Abstract": {
      "AbstractText": [
        "Biased seroprevalence estimates can occur using serological assays optimized with validation sets unrepresentative of disease spectrum in the general population. Correct interpretation of serosurveys for severe acute respiratory syndrome coronavirus 2 requires quantifying variations in sensitivity with disease severity and over time."
      ],
      "CopyrightInformation": "\u00a9 The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "EPPIcenter Program, Division of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA."
          }
        ],
        "LastName": "Takahashi",
        "ForeName": "Saki",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "EPPIcenter Program, Division of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, USA."
          }
        ],
        "LastName": "Greenhouse",
        "ForeName": "Bryan",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "EPPIcenter Program, Division of HIV, ID, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA."
          }
        ],
        "LastName": "Rodr\u00edguez-Barraquer",
        "ForeName": "Isabel",
        "Initials": "I"
      }
    ],
    "GrantList": [
      {
        "GrantID": "K24 AI144048",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "blood",
        "epidemiology",
        "immunology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Clinical Laboratory Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Seroepidemiologic Studies"
    }
  ]
}